Therapeutic-area Dossier
Neurology
Therapeutic-area Dossier for Neurology (nervous system medicines). Australian brands, active ingredients, PBS-listed treatments, PBAC outcomes — compiled…
- Brand: AJOVY
- Brand: AMANTAMED
- Brand: APO-BACLOFEN
- Brand: APO-MEMANTINE
- Brand: APO-SUMATRIPTAN
- Brand: APO-TOPIRAMATE
- Sponsor: Arrotex Pharmaceuticals
- Sponsor: Alphapharm
- Sponsor: Medsurge Pharma
- Sponsor: Novartis Pharmaceuticals
What is
Neurology Neurology covers a therapeutic area with 1093 total brands registered, of which 657 are indexable. This area encompasses pharmaceutical products used in the diagnosis, treatment and management of neurological disorders and conditions affecting the nervous system.
Brands registered in Neurology The top brands registered in this area include:
— ABILIFY — AJOVY — ALEPAM — ALLEGRON — ALODORM — ALPRAX — AMANTAMED — APO-ATOMOXETINE — APO-CLOMIPRAMINE — APO-DULOXETINE — APO-MEMANTINE
Sponsor landscape
There are 112 total sponsors active in the Neurology area. The leading sponsors include Arrotex Pharmaceuticals, Alphapharm, GM Pharma, Sandoz, Sun Pharma, Ipca Pharma, Strides Pharma Science and Accord Healthcare.
PBS and regulatory activity
There are 160 brands with PBS-listed items in the Neurology area, with the latest PBS schedule date being 1 May 2026. The latest PBAC outcome for this area is dated 1 December 2025, and the latest AusPAR is dated 4 June 2025. There are 122 brands with PBAC outcomes on record and 65 brands with AusPARs on record in this therapeutic area.